Lazard Asset Management LLC increased its stake in SINOPHARM (01099) by approximately 10.55 million shares, with a price of 17.1 Hong Kong dollars per share.
On September 20th, Lazard Asset Management LLC increased its holdings in China National Pharmaceutical Group Corporation (01099) by 10,551,655 shares, with a price of 17.1 Hong Kong dollars per share, for a total amount of approximately 180 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on September 20, Lazard Asset Management LLC increased its holdings of SINOPHARM (01099) by 1,055,165 shares, with a price of 17.1 Hong Kong dollars per share, totaling approximately 180 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 115 million, with a new holding percentage of 8.55%.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
